Alpha-glucosidase inhibitors clinical trials
A class of medicines: the studies that test any of its 3 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones. In MeSH: Glycoside Hydrolase Inhibitors.
Get an email when these change. Save the alpha-glucosidase inhibitors studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Medicines in this class
Studies that test each. A study of two counts under both, and once above.
Studies by the year they started
62 studies that test it; most in 2007 (7)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 7 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 26 · Other 43
Bayer (7) · Sanwa Kagaku Kenkyusho Co., Ltd. (6) · Takeda (4) · RenJi Hospital (2) · Nanjing First Hospital, Nanjing Medical University (2) · Merck Sharp & Dohme LLC (2) · Taichung Veterans General Hospital (2) · GWT-TUD GmbH (2)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing one of them · 69
- Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM PatientsNot yet recruitingPhase 3University of ZambiaNCT05688332Written as Voglibose + Metformin
- CGM-Guided Acarbose for Painful Diabetic NeuropathyCompletedPhase 1Shifa International HospitalNCT07436585Written as Acarbose 50 mg
- Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)WithdrawnPhase 2University of Alabama at BirminghamNCT05487859Written as Acarbose Tablets
- Study of Acarbose in LongevityTerminatedPhase 2Montefiore Medical CenterNCT02953093Written as Acarbose
- Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.TerminatedPhase 3Assistance Publique - Hôpitaux de ParisNCT03380546Written as Acarbose
- The Efficacy and Tolerability of Acarbose in Healthy IndividualsCompletedPhase 4AgelessRxNCT05542849Written as Acarbose Tablets 50mg
- Human Oral Detection of Glucose OlygomersCompletedPhase 4Oregon State UniversityNCT02589353Written as Acarbose
- Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 DiabetesStatus unknownPhase 3Nanjing First Hospital, Nanjing Medical UniversityNCT05629806Written as Acarbose
- Research of Intensive Lifestyle Intervention for PCOS Patients With IGTCompletedNot applicableRenJi HospitalNCT02446834Written as Acarbose
- Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCompletedPhase 4SanofiNCT03359837Written as Acarbose
- Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and AcarboseCompletedNot applicableNanjing First Hospital, Nanjing Medical UniversityNCT05035849Written as sitagliptin and acarbose
- Acarbose and Older Adults With Postprandial HypotensionCompletedPhase 2Kenneth MaddenNCT01914133Written as Acarbose
- Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 DiabetesCompletedPhase 4Novartis PharmaceuticalsNCT01309698Written as Voglibose
- Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM PatientsCompletedPhase 4The Catholic University of KoreaNCT01490918Written as Acarbose
- Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure PatientsCompletedPhase 3BayerNCT03349684Written as Acarbose
- Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)CompletedPhase 4Population Health Research InstituteNCT01181674Written as acarbose
- Bioequivalence Study for Acarbose/Metformin FDCCompletedPhase 1BayerNCT04065581Written as Acarbose/Metformin FDC(BAY81-9783)
- Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small IntestinesCompletedNot applicableUniversity Hospital, Gentofte, CopenhagenNCT03241303Written as Acarbose
- Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsStatus unknownPhase 4Peking Union Medical College HospitalNCT04287387Written as Acarbose Tablets
- Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.Status unknownNot applicableThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT03961659Written as Acarbose
See all 69 studies that test one of the alpha-glucosidase inhibitors →
Codes
What other systems call Alpha-glucosidase inhibitors · ClinicalTrials.gg INT008980
- MeSH (NLM) D065089Glycoside Hydrolase InhibitorsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D065089 | Glycoside Hydrolase Inhibitors | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.